trial

Study of the Activation of Proinflammatory Pathways of Toll-like Receptors in Schizophrenia Patients

NCTId NCT02897167
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Completed
Enrollment 150 (actual)
Sponsored by Fundación Marques de Valdecilla
Primary completion 2018-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
150 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2016-08
Primary completion
2018-12
Eligibility
ALL · 15 Years · 50 Years

Interventions & indications

Drugs
Retrospective study of frozen samplesProspective study of fresh samples

Sponsors

Fundación Marques de ValdecillaLead Sponsor
Centro de Investigación Biomédica en Red de Salud MentalCollaborator
Instituto de Investigación Marqués de ValdecillaCollaborator

Investigators

1
Benedicto Crespo-Facorro, ProfessorPrincipal Investigator

Sites

1 total
Santander, Spain

Facts & assertions

4 sourced
Enrollment
150
Phase
NA
Primary Completion Date
2018-12
Status
COMPLETED
relationships
The graph out of here
drug
Retrospective study of frozen samples
drug
Prospective study of fresh samples
drug
lead_sponsor
Fundación Marques de Valdecilla
company
collaborator
Centro de Investigación Biomédica en Red de Salud Mental
company
Instituto de Investigación Marqués de Valdecilla
company
indication
Psychotic Disorders
indication
Schizophrenia Spectrum and Other Psychotic Disorders
indication
Psychotic Disorders
indication
investigator
Benedicto Crespo-Facorro, Professor
person